Mittal, A;
Bhatnagar, S;
Kumar, A;
Lach-Trifilieff, E;
Wauters, S;
Li, H;
Makonchuk, DY;
... Kumar, A; + view all
(2010)
The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.
Journal of Cell Biology
, 188
(6)
pp. 833-849.
10.1083/jcb.200909117.
Preview |
Text
Foti_The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.pdf Download (10MB) | Preview |
Abstract
Skeletal muscle atrophy occurs in a variety of clinical settings, including cachexia, disuse, and denervation. Inflammatory cytokines have been shown to be mediators of cancer cachexia; however, the role of cytokines in denervation- and immobilization-induced skeletal muscle loss remains unknown. In this study, we demonstrate that a single cytokine, TNF-like weak inducer of apoptosis (TWEAK), mediates skeletal muscle atrophy that occurs under denervation conditions. Transgenic expression of TWEAK induces atrophy, fibrosis, fiber-type switching, and the degradation of muscle proteins. Importantly, genetic ablation of TWEAK decreases the loss of muscle proteins and spared fiber cross-sectional area, muscle mass, and strength after denervation. Expression of the TWEAK receptor Fn14 (fibroblast growth factor–inducible receptor 14) and not the cytokine is significantly increased in muscle upon denervation, demonstrating an unexpected inside-out signaling pathway; the receptor up-regulation allows for TWEAK activation of nuclear factor κB, causing an increase in the expression of the E3 ubiquitin ligase MuRF1. This study reveals a novel mediator of skeletal muscle atrophy and indicates that the TWEAK–Fn14 system is an important target for preventing skeletal muscle wasting.
Type: | Article |
---|---|
Title: | The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1083/jcb.200909117 |
Publisher version: | https://doi.org/10.1083/jcb.200909117 |
Language: | English |
Additional information: | © 2010 Mittal et al. This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/). |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/1529445 |
Archive Staff Only
View Item |